# ICON8 (NCT01654146)

> ICON8: Weekly Chemotherapy in Ovarian Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01654146
- Phase: PHASE3
- Status: UNKNOWN
- Sponsor: Medical Research Council
- Conditions: Ovarian Cancer
- Interventions: Carboplatin; Carboplatin; Paclitaxel; Paclitaxel
- Enrollment: 1485
- Primary outcome: Stage 1: Feasibility assessed as the number of cycles and dose intensity of protocol treatment delivered per patient.
- Primary outcome: Stage 1: Safety assessed as the rate of any ≥ grade 3 toxicity experienced per patient.
- Primary outcome: Stage 2: Progression Free Survival rate at 9 months after randomisation
- Primary outcome: Stage 3: Progression Free Survival
- Primary outcome: Stage 3: Overall Survival

## Commentary we found

- YouTube: 5
- Podcasts: 2

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=icon8-nct01654146